Targeting the forgotten transglycosylases

Biochemical Pharmacology

Volumn 71, Issue 7, 2006, Pages 957-967

  Halliday, Judy ^a   McKeveney, Declan ^a   Muldoon, Craig ^a   Rajaratnam, Premraj ^a   Meutermans, Wim ^a  

^a Alchemia Ltd   (Australia)

Author keywords

Bacterial cell wall biosynthesis; PBP; TG domain; Transglycosylase inhibitors; Transglycosylation process

Indexed keywords

AC 986446; ACL 19273; ACTAGARDIN; ANTIINFECTIVE AGENT; BAMBERMYCIN; DALBAVANCIN; GLYCOPEPTIDE; GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE INHIBITOR; LACTICIN 3147; LANTIBIOTIC; MANNOPEPTIMYCIN DERIVATIVE; MERSACIDIN; MOECINOL; MOENOMYCIN A; NATURAL PRODUCT; ORITAVANCIN; RAMOPLANIN; TEICOPLANIN; TELAVANCIN; TS 30153; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; BACTERIAL PNEUMONIA; CLINICAL TRIAL; DIARRHEA; DRUG BINDING SITE; ENZYME INHIBITION; GLYCOSYLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STRUCTURE ACTIVITY RELATION;

EID: 33644511729     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.10.030     Document Type: Article

References (99)

1. D. Kahne, C. Leimkuhler, W. Lu, and C. Walsh Glycopeptide and lipoglycopeptide antibiotics Chem. Rev. (Washington, DC, United States) 105 2 2005 425 448
2. J. Van Heijenoort Formation of the glycan chains in the synthesis of bacterial peptidoglycan Glycobiology 11 3 2001 25R 36R
3. T.D.H. Bugg Bacterial peptidoglycan biosynthesis and its inhibition Compr. Nat. Prod. Chem. 3 1999 241 294
4. U.C. Kreis, V. Varma, and B.M. Pinto Application of two-dimensional NMR spectroscopy and molecular dynamics simulations to the conformational analysis of oligosaccharides corresponding to the cell-wall polysaccharide of Streptococcus group A Int. J. Biol. Macromol. 17 3-4 1995 117 130
5. G. Yang, L. Hennig, M. Findeisen, R. Oehme, S. Giesa, and P. Welzel Studies on the synthesis of trisaccharide analogues of the antibiotic moenomycin A Helvetica Chim. Acta 87 7 2004 1794 1806
6. M. Terrak, T.K. Ghosh, J. Van Heijenoort, J. Van Beeumen, M. Lampilas, and J. Aszodi The catalytic, glycosyl transferase and acyl transferase modules of the cell wall peptidoglycan-polymerizing penicillin-binding protein 1b of Escherichia coli Mol. Microbiol. 34 2 1999 350 364
7. C.J.-M. Goffin, and Ghuysen Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs Microbiol. Mol. Biol. Rev. 62 4 1998 1079 1093
8. J. Nakagawa, S. Tamaki, S. Tomioka, and M. Matsuhashi Functional biosynthesis of cell wall peptidoglycan by polymorphic bifunctional polypeptides and penicillin-binding protein 1Bs of Escherichia coli with activities of transglycosylase and transpeptidase J. Biol. Chem. 259 22 1984 13937 13946
9. J. Paik, D. Jendrossek, and R. Hakenbeck A putative monofunctional glycosyltransferase is expressed in Ralstonia eutropha J. Bacteriol. 179 12 1997 4061 4065
10. Q.M. Wang, R.B. Peery, R.B. Johnson, W.E. Alborn, W.-K. Yeh, and P.L. Skatrud Identification and characterization of a monofunctional glycosyltransferase from Staphylococcus aureus J. Bacteriol. 183 16 2001 4779 4785
11. P. Macheboeuf, A.M. Di Guilmi, V. Job, T. Vernet, O. Dideberg, and A. Dessen Active site restructuring regulates ligand recognition in class A penicillin-binding proteins Proc. Natl. Acad. Sci. U.S.A. 102 3 2005 577 582
12. S.Y. Yousif, J.K. Broome-Smith, and B.G. Spratt Lysis of Escherichia coli by b-lactam antibiotics: deletion analysis of the role of penicillin-binding proteins 1A and 1B J. Gen. Microbiol. 131 10 1985 2839 2845
13. J. Paik, I. Kern, R. Lurz, and R. Hakenbeck Mutational analysis of the Streptococcus pneumoniae bimodular class A penicillin-binding proteins J. Bacteriol. 181 12 1999 3852 3856
14. D.C. McPherson, and D.L. Popham Peptidoglycan synthesis in the absence of class A penicillin-binding proteins in Bacillus subtilis J. Bacteriol. 185 4 2003 1423 1431
15. D. Barrett, C. Leimkuhler, L. Chen, D. Walker, D. Kahne, and S. Walker Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2 J. Bacteriol. 187 6 2005 2215 2217
16. A. Arbeloa, H. Segal, J.-E. Hugonnet, N. Josseaume, L. Dubost, and J.-P. Brouard Role of class A penicillin-binding proteins in PBP5-mediated b-lactam resistance in Enterococcus faecalis J. Bacteriol. 186 5 2004 1221 1228
17. M. Arthur, and P. Courvalin Genetics and mechanisms of glycopeptide resistance in enterococci Antimicrob. Agents Chemother. 37 8 1993 1563 1571
18. C.T. Walsh Vancomycin resistance: decoding the molecular logic Science 261 5119 1993 308 309
19. C.T. Walsh, S.L. Fisher, I.S. Park, M. Prahalad, and Z. Wu Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story Chem. Biol. 3 1 1996 21 28
20. G. Huber, and G. Nesemann Moenomycin an inhibitor of cell wall synthesis Biochem. Biophys. Res. Commun. 30 1 1968 7 13
21. K. Endler, U. Schuricht, L. Hennig, P. Welzel, U. Holst, and W. Aretz Exploratory investigations into the biosynthesis of the antibiotic moenomycin A Tetrahedron Lett. 39 1/2 1998 13 16
22. R.C. Goldman, and D. Gange Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis Curr. Med. Chem. 7 8 2000 801 820
23. P. Butaye, L.A. Devriese, and F. Haesebrouck Differences in antibiotic resistance patterns of Enterococcus faecalis and Enterococcus faecium strains isolated from farm and pet animals Antimicrob. Agents Chemother. 45 5 2001 1374 1378
24. S. Hentschel, D. Kusch, and H.J. Sinell Staphylococcus aureus in poultry - biochemical characteristics, antibiotic resistance and phage pattern (author's transl) Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe B: Hygiene, Betriebshygiene, praventive Medizin 168 5/6 1979 546 561
25. A.E. Van den Bogaard, M. Hazen, M. Hoyer, P. Oostenbach, and E.E. Stobberingh Effects of flavophospholipol on resistance in fecal Escherichia coli and enterococci of fattening pigs Antimicrob. Agents Chemother. 46 1 2002 110 118
26. J.F. Barrett Recent developments in glycopeptide antibacterials Curr. Opin. Investig. Drugs 6 8 2005 781 790
27. A. Malabarba, I. Nicas Thalia, and R.C. Thompson Structural modifications of glycopeptide antibiotics Med. Res. Rev. 17 1 1997 69 137
28. A.C. Gales, H.S. Sader, and R.N. Jones Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolated from Latin American medical centres Clin. Microbiol. Infect. 11 2 2005 95 100
29. F. Van Bambeke Glycopeptides in clinical development: pharmacological profile and clinical perspectives Curr. Opin. Pharmacol. 4 5 2004 471 478
30. D.R.P. Guay Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria Pharmacotherapy 24 1 2004 58 68
31. F. Van Bambeke, Y. Van Laethem, P. Courvalin, and P.M. Tulkens Glycopeptide antibiotics: from conventional molecules to new derivatives Drugs 64 9 2004 913 936
32. N.E. Allen, and T.I. Nicas Mechanism of action of oritavancin and related glycopeptide antibiotics FEMS Microbiol. Rev. 26 5 2003 511 532
33. S. Walker, L. Chen, Y. Hu, Y. Rew, D. Shin, and D.L. Boger Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity Chem. Rev. (Washington, DC, United States) 105 2 2005 449 475
34. D.G. McCafferty, P. Cudic, B.A. Frankel, S. Barkallah, R.G. Kruger, and W. Li Chemistry and biology of the ramoplanin family of peptide antibiotics Biopolymers 66 4 2002 261 284
35. P.J. Petersen, T.Z. Wang, R.G. Dushin, and P.A. Bradford Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin a, and other antimicrobial agents against Gram-positive clinical isolates Antimicrob. Agents Chemother. 48 3 2004 739 746
36. H. Brotz, G. Bierbaum, P.E. Reynolds, and H.-G. Sahl The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation Eur. J. Biochem. 246 1 1997 193 199
37. M.J. Sofia, N. Allanson, N.T. Hatzenbuhler, R. Jain, R. Kakarla, and N. Kogan Discovery of novel disaccharide antibacterial agents using a combinatorial library approach J. Med. Chem. 42 17 1999 3193 3198
38. R.C. Goldman, E.R. Baizman, C.B. Longley, and A.A. Branstrom Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding FEMS Microbiol. Lett. 183 2 2000 209 214
39. M. Ge, Z. Chen, H.R. Onishi, J. Kohler, L.L. Silver, and R. Kerns Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala Science (Washington, DC) 284 5413 1999 507 511
40. L. Chen, D. Walker, B. Sun, Y. Hu, S. Walker, and D. Kahne Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate Proc. Natl. Acad. Sci. U.S.A. 100 10 2003 5658 5663
41. S.S. Printsevskaya, A.Y. Pavlov, E.N. Olsufyeva, E.P. Mirchink, and M.N. Preobrazhenskaya Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics J. Med. Chem. 46 7 2003 1204 1209
42. R. Sinha Roy, P. Yang, S. Kodali, Y. Xiong, R.M. Kim, and P.R. Griffin Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis Chem. Biol. 8 11 2001 1095 1106
43. C. Leimkuhler, L. Chen, D. Barrett, G. Panzone, B. Sun, and B. Falcone Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics J. Am. Chem. Soc. 127 10 2005 3250 3251
44. J.K. Judice, and J.L. Pace Semi-synthetic glycopeptide antibacterials Bioorg. Med. Chem. Lett. 13 23 2003 4165 4168
45. L. Chen, Y. Yuan, J.S. Helm, Y. Hu, Y. Rew, and D. Shin Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics J. Am. Chem. Soc. 126 24 2004 7462 7463
46. P. Cudic, D.C. Behenna, J.K. Kranz, R.G. Kruger, A.J. Wand, and Y.I. Veklich Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin Chem. Biol. 9 8 2002 897 906
47. P. Cudic, J.K. Kranz, D.C. Behenna, R.G. Kruger, H. Tadesse, and A.J. Wand Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation Proc. Natl. Acad. Sci. U.S.A. 99 11 2002 7384 7389
48. M.-C. Lo, J.S. Helm, G. Sarngadharan, I. Pelczer, and S. Walker A new structure for the substrate-binding antibiotic ramoplanin J. Am. Chem. Soc. 123 35 2001 8640 8641
49. Y. Hu, J.S. Helm, L. Chen, X.-Y. Ye, and S. Walker Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II J. Am. Chem. Soc. 125 29 2003 8736 8737
50. H. Brotz, M. Josten, I. Wiedemann, U. Schneider, F. Gotz, and G. Bierbaum Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics Mol. Microbiol. 30 2 1998 317 327
51. S.-T. Hsu, E. Breukink, B. de Kruijff, R. Kaptein, A.M.J.J. Bonvin, and N.A.J. Van Nuland Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles Biochemistry 41 24 2002 7670 7676
52. H.E. van Heusden, B. de Kruijff, and E. Breukink Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin Biochemistry 41 40 2002 12171 12178
53. E. Breukink, H.E. van Heusden, P.J. Vollmerhaus, E. Swiezewska, L. Brunner, and S. Walker Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes J. Biol. Chem. 278 22 2003 19898 19903
54. H.E. Hasper, B. De Kruijff, and E. Breukink Assembly and stability of nisin-lipid II pores Biochemistry 43 36 2004 11567 11575
55. H. Brotz, G. Bierbaum, K. Leopold, P.E. Reynolds, and H.-G. Sahl The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II Antimicrob. Agents Chemother. 42 1 1998 154 160
56. S.-T.D. Hsu, E. Breukink, G. Bierbaum, H.-G. Sahl, B. De Kruijff, and R. Kaptein NMR study of Mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity J. Biol. Chem. 278 15 2003 13110 13117
57. N.I. Martin, T. Sprules, M.R. Carpenter, P.D. Cotter, C. Hill, and R.P. Ross Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity Biochemistry 43 11 2004 3049 3056
58. H. He, R.T. Williamson, B. Shen, E.I. Graziani, H.Y. Yang, and S.M. Sakya Mannopeptimycins, novel antibacterial glycopeptides from Streptomyces hygroscopicus LL-AC98 J. Am. Chem. Soc. 124 33 2002 9729 9736
59. M.P. Singh, P.J. Petersen, W.J. Weiss, J.E. Janso, S.W. Luckman, and E.B. Lenoy Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities Antimicrob. Agents Chemother. 47 1 2003 62 69
60. A. Ruzin, G. Singh, A. Severin, Y. Yang, R.G. Dushin, and A.G. Sutherland Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant Gram-positive bacteria Antimicrob. Agents Chemother. 48 3 2004 728 738
61. H. He, and Mannopeptimycins A novel class of glycopeptide antibiotics active against gram-positive bacteria Appl. Microbiol. Biotechnol. 67 4 2005 444 452
62. H. He, B. Shen, P.J. Petersen, W.J. Weiss, H.Y. Yang, and T.-Z. Wang Mannopeptimycin esters and carbonates, potent antibiotic agents against drug-resistant bacteria Bioorg. Med. Chem. Lett. 14 1 2004 279 282
63. P.-E. Sum, D. How, N. Torres, P.J. Petersen, J. Ashcroft, and E.I. Graziani Synthesis and evaluation of ether and halogenated derivatives of mannopeptimycin glycopeptide antibiotics Bioorg. Med. Chem. Lett. 13 16 2003 2805 2808
64. P.-E. Sum, D. How, N. Torres, P.J. Petersen, E.B. Lenoy, and W.J. Weiss Novel ether derivatives of mannopeptimycin glycopeptide antibiotic Bioorg. Med. Chem. Lett. 13 6 2003 1151 1155
65. R.G. Dushin, T.-Z. Wang, P.-E. Sum, H. He, A.G. Sutherland, and J.S. Ashcroft Hydrophobic acetal and ketal derivatives of mannopeptimycin-a and desmethylhexahydromannopeptimycin-a: semisynthetic glycopeptides with potent activity against Gram-positive bacteria J. Med. Chem. 47 14 2004 3487 3490
66. W.J. Weiss, T. Murphy, E. Lenoy, and M. Young In vivo efficacy and pharmacokinetics of AC98-6446, a novel cyclic glycopeptide, in experimental infection models Antimicrob. Agents Chemother. 48 5 2004 1708 1712
67. A.M. Di Guilmi, N. Mouz, J.P. Andrieu, J. Hoskins, S.R. Jaskunas, and J. Gagnon Identification, purification, and characterization of transpeptidase and glycosyltransferase domains of Streptococcus pneumoniae penicillin-binding protein 1a J. Bacteriol. 180 21 1998 5652 5659
68. A.M. Di Guilmi, A. Dessen, O. Dideberg, and T. Vernet Functional characterization of penicillin-binding protein 1b from Streptococcus pneumoniae J. Bacteriol. 185 5 2003 1650 1658
69. A.M. Di Guilmi, A. Dessen, O. Dideberg, and T. Vernet The glycosyltransferase domain of penicillin-binding protein 2a from Streptococcus pneumoniae catalyzes the polymerization of murein glycan chains J. Bacteriol. 185 15 2003 4418 4423
70. P. Welzel, F. Kunisch, F. Kruggel, H. Stein, J. Scherkenbeck, and A. Hiltmann Moenomycin A: minimum structural requirements for biological activity Tetrahedron 43 3 1987 585 598
71. Y. Van Heijenoort, M. Leduc, H. Singer, and J. Van Heijenoort Effects of moenomycin on Escherichia coli J. Gen. Microbiol. 133 3 1987 667 674
72. K. Stembera, S. Vogel, A. Buchynskyy, J.A. Ayala, and P. Welzel A surface plasmon resonance analysis of the interaction between the antibiotic moenomycin A and penicillin-binding protein 1b Chembiochem 3 6 2002 559 565
73. S. Vogel, K. Stembera, L. Hennig, M. Findeisen, S. Giesa, and P. Welzel Moenomycin analogs with long-chain amine lipid parts from reductive amination Tetrahedron 57 19 2001 4147 4160
74. S. Vogel, K. Stembera, L. Hennig, M. Findeisen, S. Giesa, and P. Welzel Moenomycin analogues with modified lipid side chains from indium-mediated Barbier-type reactions Tetrahedron 57 19 2001 4139 4146
75. S. Vogel, A. Buchynskyy, K. Stembera, K. Richter, L. Hennig, and D. Muller Some selective reactions of moenomycin A Bioorg. Med. Chem. Lett. 10 17 2000 1963 1965
76. F.-T. Ferse, K. Floeder, L. Hennig, M. Findeisen, P. Welzel, and D. Muller Acceptor site recognition of transglycosylase inhibitors a b-d-glucopyranosyl-(1->2)-a-d-glucopyranuronamide-derived moenomycin analog Tetrahedron 55 12 1999 3749 3766
77. S. Riedel, A. Donnerstag, L. Hennig, P. Welzel, J. Richter, and K. Hobert Synthesis and transglycosylase-inhibiting properties of a disaccharide analog of moenomycin A lacking substitution at C-4 of unit F Tetrahedron 55 7 1999 1921 1936
78. N. Ei-Abadla, M. Lampilas, L. Hennig, M. Findeisen, P. Welzel, and D. Muller Moenomycin A: the role of the methyl group in the moenuronamide unit and a general discussion of structure-activity relationships Tetrahedron 55 3 1999 699 722
79. O. Ritzeler, L. Hennig, M. Findeisen, P. Welzel, D. Mueller, and A. Markus Synthesis of trisaccharide analog of monoenomycin A12. Implications of new moenomycin structure-activity relationships Tetrahedron 53 5 1997 1675 1694
80. U. Kempin, L. Hennig, P. Welzel, S. Marzian, D. Mueller, and H.-W. Fehlhaber Introduction of a terminal hydroxy group into the lipid part of a moenomycin-type transglycosylase inhibitor suppresses antibiotic activity Tetrahedron 51 31 1995 8471 8482
81. S. Marzian, M. Happel, U. Wagner, D. Mueller, P. Welzel, and H.-W. Fehlhaber Moenomycin A: reactions at the lipid part. New structure-activity relations Tetrahedron 50 18 1994 5299 5308
82. J. Luening, U. Moeller, D. Mueller, P. Welzel, A. Markus, and V. van Heijenoort The first synthesis of a moenomycin-type transglycosylase inhibitor Tetrahedron 49 46 1993 10587 10596
83. J. Scherkenbeck, A. Hiltmann, K. Hobert, W. Bankova, T. Siegels, and M. Kaiser Structures of some moenomycin antibiotics - inhibitors of peptidoglycan biosynthesis Tetrahedron 49 15 1993 3091 3100
84. U. Moeller, K. Hobert, A. Donnerstag, P. Wagner, D. Mueller, and H.W. Fehlhaber Moenomycin A - structure-activity relations synthesis of the d-galacturonamide analog of the smallest antibiotically active degradation product of moenomycin A Tetrahedron 49 8 1993 1635 1648
85. K.H. Metten, K. Hobert, S. Marzian, U.E. Hackler, U. Heinz, and P. Welzel The first enzymic degradation products of the antibiotic moenomycin A Tetrahedron 48 39 1992 8401 8418
86. H.W. Fehlhaber, M. Girg, G. Seibert, K. Hobert, P. Welzel, and Y. Van Heijenoort Moenomycin A: a structural revision and new structure-activity relations Tetrahedron 46 5 1990 1557 1568
87. H. Hohgardt, W. Dietrich, H. Kuehne, D. Mueller, D. Grazelak, and P. Welzel Synthesis of two structural analogs of the smallest antibiotically active degradation product of moenomycin A Tetrahedron 44 18 1988 5771 5790
88. U. Eichelberger, I. Neundorf, L. Hennig, M. Findeisen, S. Giesa, and D. Muller Synthesis of analogues of the 2-O-alkyl glycerate part of the moenomycins Tetrahedron 58 3 2002 545 559
89. P. Butaye, L.A. Devriese, and F. Haesebrouck Influence of different medium components on the in vitro activity of the growth-promoting antibiotic flavomycin against enterococci J. Antimicrob. Chemother. 46 5 2000 713 716
90. B. Sun, Z. Chen, U.S. Eggert, S.J. Shaw, J.V. LaTour, and D. Kahne Hybrid glycopeptide antibiotics J. Am. Chem. Soc. 123 50 2001 12722 12723
91. T. Ruhl, M. Daghish, A. Buchynskyy, K. Barche, D. Volke, and K. Stembera Studies on the interaction of the antibiotic moenomycin A with the enzyme penicillin-binding protein 1b Bioorg. Med. Chem. 11 13 2003 2965 2981
92. G. Range, R. Kraehmer, P. Welzel, D. Mueller, G.F. Herrmann, and U. Kragl A chemoenzymic approach towards moenomycin structural analog Tetrahedron 53 5 1997 1695 1706
93. G. Yang, M. Mansourova, L. Hennig, M. Findeisen, R. Oehme, and S. Giesa Studies on the synthesis of di- and trisaccharide analogues of moenomycin A. Modifications in unit E and in the lipid part Helvetica Chim. Acta 87 7 2004 1807 1824
94. S. Garneau, L. Qiao, L. Chen, S. Walker, and J.C. Vederas Synthesis of mono- and disaccharide analogs of moenomycin and lipid II for inhibition of transglycosylase activity of penicillin-binding protein 1b Bioorg. Med. Chem. 12 24 2004 6473 6494
95. S.J. Hecker, M.L. Minich, and K. Lackey Synthesis of compounds designed to inhibit bacterial cell wall transglycosylation J. Org. Chem. 55 16 1990 4904 4911
96. G. Brooks, P.D. Edwards, J.D.I. Hatto, T.C. Smale, and R. Southgate Synthesis of derivatives of muramic acid and C-1 homologated a-d-glucose as potential inhibitors of bacterial transglycosylase Tetrahedron 51 29 1995 7999 8014
97. B. Schwartz, J.A. Markwalder, and Y. Wang Lipid II: total synthesis of the bacterial cell wall precursor and utilization as a substrate for glycosyltransfer and transpeptidation by penicillin binding protein (PBP) 1b of Escherichia coli J. Am. Chem. Soc. 123 47 2001 11638 11643
98. M.S. VanNieuwenhze, S.C. Mauldin, M. Zia-Ebrahimi, B.E. Winger, W.J. Hornback, and S.L. Saha The first total synthesis of lipid II: the final monomeric intermediate in bacterial cell wall biosynthesis J. Am. Chem. Soc. 124 14 2002 3656 3660
99. B. Chandrakala, R.K. Shandil, U. Mehra, S. Ravishankar, P. Kaur, and V. Usha High-throughput screen for inhibitors of transglycosylase and/or transpeptidase activities of Escherichia coli penicillin-binding protein 1b Antimicrob. Agents Chemother. 48 1 2004 30 40